Search

Search Results

• An Update on Management of Nonalcoholic Fatty Liver Disease & Nonalcoholic Steatohepapititis is the Time Ripe for Achieving Resolution of NAFLD & NASH Soon

  Kulvinder Kochar Kaur, Gautam Allahbadia, Mandeep Singh

  44-59

  
  Article ID: 3580
  560  (Abstract) 189  (Download)
  

  Abstract:

  We earlier reviewed how obesity has assumed an endemic/pandemic

  proportions that has resulted in escalating incidence and prevalence of

  associated escalating worldwide incidence of Metabolic Syndrome (MetS)

  with non alcoholic fatty liver disease (NAFLD), that is correlated with

  enhanced morbidity. Later we tried to detail how probiotics, L-Carnitine

  (LC), Nicotinamide Ribose (NR) Combination, along with Apical Sodium

  Dependent Bile Acids Transporter... More

  2021-09-03

• The Association of Non Viral Liver Diseases from NAFLD to NASH to HCC with the Pandemic of Obesity, Type 2 Diabetes, or Diabesity & Metabolic Syndrome Etiopathogenetic Correlation along with Utilization for Diagnostic & Therapeutic Purposes-A Systematic Review

  Kulvinder Kochar Kaur, Gautam Allahbadia, Mandeep Singh

  10-33

  
  Article ID: 3520
  699  (Abstract) 264  (Download)
  

  Abstract:

  Earlier we have been reviewing the etiopathogenesis (EP) of obesity, type2 Diabetes mellitus (T2DM), Metabolic Syndrome (MetS), Non Alcoholic Fatty Acid Liver Disease (NAFLD) non alcoholic steatohepapititis (NASH), along with its propagation to Hepatocellular carcinoma (HCC) in addition to their therapies exhaustively. T2DM continues to be a major health issue with reaching epidemic to pandemic... More

  2021-08-31